Therefore, this systematic review and dose–response meta-analysis aimed to pool the results of various related controlled trials (CTs) assessing the effects of ACV on glycemic indices and insulin sensitivity in patients with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.